Literature DB >> 11226692

Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.

D P Devine1, S J Watson, H Akil.   

Abstract

We examined the effects of the neuropeptide nociceptin/orphanin FQ on activity of the limbic-hypothalamic-pituitary-adrenal axis (also known as the stress axis) in rats. This axis regulates important metabolic functions, and initiates critical neuroendocrine responses that cope with environmental threats and challenges to homeostatic functioning. Disregulation of the limbic-hypothalamic-pituitary-adrenal axis is associated with impaired physical and psychological health. In the present experiments, rats were treated with intracerebroventricular injections of nociceptin/orphanin FQ in the presence or absence of acute stressors. Plasma adrenocorticotrophic hormone and corticosterone concentrations were assayed 15 or 30min after injections. In the rats that were not exposed to stress, nociceptin/orphanin FQ produced dose-orderly elevations of circulating adrenocorticotrophic hormone and corticosterone concentrations. These effects were also found after administration of the nociceptin/orphanin FQ analogues, des-Phe orphanin FQ and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin((1-13))NH(2). In rats that were exposed to the mild stress of a novel environment, nociceptin/orphanin FQ administration enhanced the stress-induced elevations of plasma adrenocorticotrophic hormone concentrations and prolonged the stress-induced elevations of plasma corticosterone concentrations. In rats that were exposed to restraint stress, nociceptin/orphanin FQ administration did not augment the stress-induced elevations in plasma hormones, perhaps because of a ceiling effect. We conclude that administration of nociceptin/orphanin FQ activates neuroendocrine activity of the limbic-hypothalamic-pituitary-adrenal axis even in the absence of a stressor, and may delay the shutdown of these physiological responses after exposure to acute mild stress. In light of the known functions of this axis, it appears that nociceptin/orphanin FQ participates in the regulation of important metabolic functions, and may be implicated in physiological responses to stress. This interaction between nociceptin/orphanin FQ and the limbic-hypothalamic-pituitary-adrenal axis implicates nociceptin/orphanin FQ in important aspects of physiological and psychological well-being.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226692     DOI: 10.1016/s0306-4522(00)00517-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  27 in total

1.  Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.

Authors:  Roberto Sebastián Miranda-Morales; Michael E Nizhnikov; Dustin H Waters; Norman E Spear
Journal:  Behav Brain Res       Date:  2013-02-21       Impact factor: 3.332

Review 2.  How mental stress affects endothelial function.

Authors:  Noboru Toda; Megumi Nakanishi-Toda
Journal:  Pflugers Arch       Date:  2011-09-23       Impact factor: 3.657

3.  Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA-GABA transmission in highly addicted rats.

Authors:  Marsida Kallupi; Lieselot L G Carrette; Jenni Kononoff; Leah C Solberg Woods; Abraham A Palmer; Paul Schweitzer; Olivier George; Giordano de Guglielmo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-13       Impact factor: 11.205

4.  Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure.

Authors:  Maureen T Cruz; Melissa A Herman; Marsida Kallupi; Marisa Roberto
Journal:  Biol Psychiatry       Date:  2011-12-06       Impact factor: 13.382

Review 5.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

6.  Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.

Authors:  Andre Der-Avakian; Manoranjan S D'Souza; David N Potter; Elena H Chartoff; William A Carlezon; Diego A Pizzagalli; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2017-03-09       Impact factor: 4.530

7.  Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).

Authors:  Steven D Chang; Lawrence E Brieaddy; Joseph D Harvey; Anita H Lewin; S Wayne Mascarella; Herbert H Seltzman; P Anantha Reddy; Ann M Decker; Charles J McElhinny; Desong Zhong; Elisha E Peterson; Hernán A Navarro; Michael R Bruchas; F Ivy Carroll
Journal:  ACS Chem Neurosci       Date:  2015-09-30       Impact factor: 4.418

8.  Effect of orphanin FQ/nociceptin (OFQ/N) and isoflurane on the prolactin secretory response in OFQ/N knockout mice.

Authors:  Kelly L Zullig; Emily Murphree; Rainer K Reinscheid; James Janik; Phyllis Callahan
Journal:  Peptides       Date:  2007-07-14       Impact factor: 3.750

9.  Estradiol upregulates progesterone receptor and orphanin FQ colocalization in arcuate nucleus neurons and opioid receptor-like receptor-1 expression in proopiomelanocortin neurons that project to the medial preoptic nucleus in the female rat.

Authors:  Nayna M Sanathara; Justine Moreas; Matthew Mahavongtrakul; Kevin Sinchak
Journal:  Neuroendocrinology       Date:  2014-05-09       Impact factor: 4.914

Review 10.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.